Results will be presented at the national congress of AVEPA, held in Barcelona on 9-11 November 2017The results of this new trial confirmed that nucleotides included in Impromune delay progression of leishmaniasis in healthy dogs that have been infected with the disease
The poster on a multicenter study carried out by researchers of the Murcia University, the Complutense University of Madrid, Tufts University and Bioiberica, has received the prize for best free communication presented at the Southern European Veterinary Conference
This investigation demonstrated the efficacy of Impromune for the treatment of canine leishmaniosis